Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells

Lin Li(Tongji Hospital), Jiafu Ji(Peking University)

Oncology Reports

March 9, 2016

10.3892/or.2016.4666

Cited by 21

Related Papers

ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury

|International Journal of Molecular Sciences|2023|204

RETRACTED ARTICLE: MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1

|British Journal of Cancer|2014|115

KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer

|PLoS ONE|2017|81

Cholesterol removal improves performance of a model biomimetic system to co-deliver a photothermal agent and a STING agonist for cancer immunotherapy

|Nature Communications|2023|53

Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway

|International Journal of Oncology|2019|52